PubRank

Hartmut Hengel

Author PubWeight™ 75.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Host immune system gene targeting by a viral miRNA. Science 2007 5.10
2 Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol 2003 3.02
3 Decoding human cytomegalovirus. Science 2012 2.98
4 MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 2002 2.66
5 Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat Immunol 2011 2.51
6 Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2005 2.40
7 Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 2008 2.35
8 A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol 2011 2.03
9 Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 2002 1.92
10 A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med 2005 1.68
11 Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies. J Neurol Neurosurg Psychiatry 2012 1.66
12 Early clinical experiences with the new influenza A (H1N1/09). Dtsch Arztebl Int 2009 1.65
13 NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 2005 1.60
14 Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 2004 1.58
15 Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol 2004 1.55
16 NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 2010 1.38
17 The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med 2006 1.27
18 Rapid replacement of endemic measles virus genotypes. J Gen Virol 2002 1.25
19 Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 2005 1.21
20 Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol 2008 1.19
21 The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling. J Virol 2011 1.17
22 IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J Clin Invest 2014 1.17
23 Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2. J Virol 2008 1.16
24 Laboratory investigations are indispensable to monitor the progress of measles elimination--results of the German Measles Sentinel 1999-2003. J Clin Virol 2004 1.11
25 Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog 2011 1.11
26 Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? J Gen Virol 2005 1.06
27 The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol 2008 1.03
28 Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells. PLoS Pathog 2011 1.00
29 A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. J Virol 2004 0.99
30 CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus. Mult Scler 2010 0.98
31 Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase. Hepatology 2009 0.95
32 c-Src is required for complex formation between the hepatitis C virus-encoded proteins NS5A and NS5B: a prerequisite for replication. Hepatology 2011 0.94
33 "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells. J Immunol 2013 0.92
34 Vaccination against infection in patients with multiple sclerosis. Nat Rev Neurol 2012 0.91
35 Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells. PLoS Pathog 2011 0.90
36 The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. J Virol 2008 0.90
37 Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver? Cell Mol Immunol 2014 0.90
38 Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol 2009 0.90
39 Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses. Mol Immunol 2011 0.89
40 The role of multiplex PCR in respiratory tract infections in children. Dtsch Arztebl Int 2014 0.87
41 Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J Biol Chem 2005 0.87
42 The crucial role of molecular diagnostics. Dtsch Arztebl Int 2014 0.87
43 Mouse cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and controls activation pathways of the IFN-beta enhanceosome. J Gen Virol 2008 0.86
44 Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription. J Virol 2011 0.86
45 Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc Natl Acad Sci U S A 2013 0.85
46 Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response. J Immunol 2014 0.85
47 Herpesviral Fcgamma receptors: culprits attenuating antiviral IgG? Int Immunopharmacol 2004 0.84
48 CMV-encoded Fcγ receptors: modulators at the interface of innate and adaptive immunity. Semin Immunopathol 2014 0.84
49 The human cytomegalovirus-specific UL1 gene encodes a late-phase glycoprotein incorporated in the virion envelope. J Virol 2012 0.82
50 The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope. Cell Microbiol 2006 0.82
51 HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis. Hum Immunol 2003 0.80
52 A natural tapasin isoform lacking exon 3 modifies peptide loading complex function. Eur J Immunol 2013 0.80
53 A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors. J Immunol Methods 2012 0.79
54 Cytomegalovirus immune evasion of myeloid lineage cells. Med Microbiol Immunol 2015 0.78
55 High genotypic diversity and a novel variant of human cytomegalovirus revealed by combined UL33/UL55 genotyping with broad-range PCR. Virol J 2009 0.77
56 Checks and balances between human cytomegalovirus replication and indoleamine-2,3-dioxygenase. J Gen Virol 2013 0.77
57 Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization. PLoS One 2011 0.77
58 Genetic analysis and antigenic characterization of human respiratory syncytial virus group A viruses isolated in Germany 1996-2008. Virus Genes 2013 0.76
59 [University medical education in transition]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009 0.76
60 Interplay between CMVs and interferon signaling: implications for pathogenesis and therapeutic intervention. Future Microbiol 2012 0.76
61 RAIDD Mediates TLR3 and IRF7 Driven Type I Interferon Production. Cell Physiol Biochem 2016 0.75
62 Noncontrolled trial of monovalent AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1) in long-term dialysis patients and transplant recipients. Am J Kidney Dis 2011 0.75